Composition for use in treating retinal cell death and in reducing intraocular pressure

摘要

The present invention is directed towards MPDTE (methoxypolyethylene glycol ester of diethylenetriaminepentaacetic acid) and compositions comprising MPDTE for use in (i) the treatment of retinal cell death resulting from glaucoma in a patient, and (ii) in reducing intraocular pressure in a patient.